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Strain Accession CDS CDS CDS CDS CDS
Original Re-annot Glimmer GeneMark BLAST
Bacillus anthracis – 13 genomes
A0174 (Draft) NZ ABLT01000001 5198 5512 5641 5782 3302
A0193 (Draft) NZ ABKF01000001 5309 5601 5740 5889 3360
A0389 (Draft) NZ ABLB01000001 5296 5644 5783 5940 3398
A0442 (Draft) NZ ABKG01000001 5256 5598 5742 5866 3353
A0465 (Draft) NZ ABLH01000001 5300 5649 5782 5925 3386
A0488 (Draft) NZ ABJC01000001 5288 5599 5733 5900 3358
A2012 (Draft) NZ AAAC02000001 5352 5474 5892 5939 3341
Tsiankovskii-I (Draft) NZ ABDN01000001 6051 5704 5838 6025 3399
A0248 (Finished) NC 012659 5291 5711 5855 6005 3477
AE017225 (Finished) AE017225 5287 5427 5563 5694 3360
Ames (Finished) NC 003997 5311 5432 5568 5695 3362
Ames ancestor (Finished) NC 007530 5617 5713 5856 6007 3477
CDC684 (Finished) NC 012581 5902 5715 5859 6016 3477
Escherichia coli – 15 genomes
536 (Finished) NC 008253 4629 4553 4787 4699 4190
APEC01 (Finished) NC 008563 4879 5208 5508 5385 4524
CFT073 (Finished) NC 004431 5378 4894 5150 5055 4400
E24377A (Finished) NC 009801 4997 4947 5174 5138 4474
EDL933 (Finished) NC 002655 5419 5366 5744 5564 4566
HS (Finished) NC 009800 4384 4316 4430 4449 4117
K12 (Finished) NC 000913 4244 4320 4443 4442 4294
Sakai (Finished) NC 002695 5341 5345 5672 5534 4563
UT189 (Finished) NC 007946 5211 4822 5054 4979 4342
101 1 (Draft) NZ AAMK01000001 4234 4700 4852 4876 4334
B171 (Draft) NZ AAJX01000001 4705 5229 5463 5416 4574
B7A (Draft) NZ AAJT01000001 4628 5070 5257 5287 4494
E110019 (Draft) NZ AAJW01000001 4742 5239 5507 5448 4550
E22 (Draft) NZ AAJV01000001 4781 5328 5607 5544 4550
F11 (Draft) NZ AAJU01000001 4461 4884 5151 5046 4353
Neisseria meningitidis – 14 genomes
053442 (Finished) NC 010120 N/A 2020 Not performed
FAM18 (Finished) NC 008767 N/A 1918 Not performed
MC58 (Finished) NC 003112 N/A 2063 Not performed
Z2491 (Finished) NC 003116 N/A 2049 Not performed
alpha14 (Finished) NC 013016 N/A 2059 Not performed
alpha153 (Draft) N/A N/A 2354 Not performed
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alpha275 (Draft) N/A N/A 2565 Not performed
NM10699 (Draft) N/A N/A 2110 2494 2366 1317
NM13220 (Draft) N/A N/A 2299 2725 2530 1353
NM15141 (Draft) N/A N/A 2184 2578 2411 1369
NM15293 (Draft) N/A N/A 2063 2040 2062 1285
NM18575 (Draft) N/A N/A 2471 2927 2751 1495
NM5178 (Draft) N/A N/A 2097 2510 2377 1315
NM9261 (Draft) N/A N/A 2110 2553 2370 1341
Staphylococcus aureus – 19 genomes
JKD6008 (Draft) NZ ABRZ01000084 2662 2681 2733 2791 1854
JKD6009 (Draft) NZ ABSA01000082 2684 2666 2720 2776 1843
MN8 (Draft) NZ ACJA01000014 2901 2714 2768 2845 1841
TCH60 (Draft) NZ ACHC01000045 2738 2551 2613 2666 1816
USA300 TCH959 (Draft) NZ AASB01000107 2853 2784 2826 2936 1899
COL (Finished) NC 002951 2618 2568 2612 2680 1843
JH1 (Finished) NC 009632 2780 2726 2775 2835 1890
JH9 (Finished) NC 009487 2726 2726 2773 2836 1890
MRSA252 (Finished) NC 002952 2656 2669 2728 2792 1888
MRSA USA300 TCH1516 (Finished) NC 010079 2689 2696 2744 2805 1890
MSSA476 (Finished) NC 002953 2598 2555 2599 2671 1834
MW2 (Finished) NC 003923 2632 2541 2580 2668 1832
Mu3 (Finished) NC 009782 2698 2647 2701 2748 1876
Mu50 (Finished) NC 002758 2731 2677 2730 2778 1885
N315 (Finished) NC 002745 2619 2578 2624 2677 1880
NCTC8325 (Finished) NC 007795 2892 2608 2660 2729 1830
Newman (Finished) NC 009641 2614 2677 2722 2805 1841
RF122 (Finished) NC 007622 2515 2589 2630 2707 1841
USA300 (Finished) NC 007793 2604 2701 2756 2806 1884
Streptococcus agalactiae – 8 genomes
18RS21 (Draft) NZ AAJO01000553 2146 2179 2326 2448 1316
515 (Draft) NZ AAJQ01000155 2275 2150 2248 2203 1356
COH1 (Draft) NZ AAJR01000393 2376 2295 2437 2341 1414
H36B (Draft) NZ AAJS01000345 2376 2305 2466 2354 1430
CJB111 (Draft) NZ AAJP01000255 2197 2099 2209 2137 1363
NEM316 (Finished) NC 004368 2094 2127 2191 2161 1358
2603V/R (Finished) NC 004116 2124 2108 2164 2146 1385
A909 (Finished) NC 007432 1996 2060 2127 2094 1387
Streptococcus pneumoniae – 26 genomes
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CDC0288-04 (Draft) NZ ABGF01000001 1825 2015 2105 2131 1311
CDC1087-00 (Draft) NZ ABFT01000001 1763 2153 2230 2329 1369
CDC1873-00 (Draft) NZ ABFS01000001 2026 2297 2390 2464 1372
CDC3059-06 (Draft) NZ ABGG01000001 2088 2293 2373 2456 1327
MLV016 (Draft) NZ ABGH01000001 1851 2163 2253 2340 1393
SP11-BS70 (Draft) NZ ABAC01000001 2365 2095 2154 2221 1343
SP14-BS69 (Draft) NZ ABAD01000001 2807 2524 2625 2675 1461
SP18-BS74 (Draft) NZ ABAE01000001 2415 2144 2200 2282 1377
SP19-BS75 (Draft) NZ ABAF01000001 2480 2220 2300 2339 1371
SP195 (Draft) NZ ABGE01000001 1945 2204 2297 2353 1331
SP23-BS72 (Draft) NZ ABAG01000001 2416 2154 2227 2294 1337
SP3-BS71 (Draft) NZ AAZZ01000001 2378 2110 2191 2250 1334
SP6-BS73 (Draft) NZ ABAA01000001 2507 2240 2298 2373 1380
SP9-BS68 (Draft) NZ ABAB01000001 2429 2159 2236 2298 1336
TIGR4-454 (Draft) NZ AAGY02000001 1878 1994 2036 2117 1294
70585 (Finished) NC 012468 2202 2214 2289 2340 1364
ATCC700669 (Finished) NC 011900 1990 2195 2300 2319 1357
CGSP14 (Finished) NC 010582 2206 2164 2231 2293 1353
D39 (Finished) NC 008533 1914 2031 2100 2149 1306
G54 MLSTST63 (Finished) NC 011072 2115 2085 2163 2199 1326
Hungary19A-6 (Finished) NC 010380 2155 2249 2338 2365 1358
JJA (Finished) NC 012466 2123 2118 2203 2247 1328
P1031 (Finished) NC 012467 2073 2135 2221 2252 1331
R6 (Finished) NC 003098 2043 2021 2087 2144 1301
TIGR4 (Finished) NC 003028 2094 2139 2209 2268 1354
Taiwan19F-14 (Finished) NC 012469 2044 2092 2158 2224 1309
Streptococcus pyogenes – 14 genomes
M49591 (Draft) NZ AAFV01000001 1365 1426 1457 1501 846
M1GAS (Finished) NC 002737 1697 1791 1839 1863 1177
MGAS10270 (Finished) NC 008022 1987 1894 1946 1976 1183
MGAS10394 (Finished) NC 006086 1886 1826 1874 1911 1197
MGAS10750 (Finished) NC 008024 1979 1893 1950 1972 1199
MGAS2096 (Finished) NC 008023 1898 1813 1853 1898 1202
MGAS315 (Finished) NC 004070 1865 1864 1920 1964 1167
MGAS5005 (Finished) NC 007297 1865 1788 1840 1871 1187
MGAS6180 (Finished) NC 007296 1894 1813 1871 1897 1176
MGAS8232 (Finished) NC 003485 1845 1881 1924 1966 1191
MGAS9429 (Finished) NC 008021 1877 1755 1800 1826 1163
Mabfredo (Finished) NC 009332 1745 1802 1851 1893 1175
NZ131 (Finished) NC 011375 1699 1734 1811 1817 1162
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SSI-1 (Finished) NC 004606 1861 1862 1912 1961 1167
Table S1: Accession information for all bacterial genomes used
in this project. Strain lists the strain name. Accession is the
NCBI accession identifier that is hyper-linked to the NCBI
website. The final 5 columns denote the number of cod-
ing sequences (CDS) identified in the genome using various
schemes: first, the number of CDS in the annotated genome
(if available), then the number of CDS identified using the
re-annotation scheme described in Materials and Methods
(CDS Re-annot), and finally the number of CDS identified
using Glimmer1, GeneMarkS2 and BLAST3.
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Ec Nm Sag Spy Spn Sau Ba
Ec × ◦ ◦ ? ? ? ?
Nm × ◦ ◦ ? ? ?
Sag × ◦ ◦ ◦ ?
Spy × ◦ ? ?
Spn × ? ?
Sau × ?
Ba ×
Table S2: Significant fluidity differences for i = 0.5 and c = 0.5 (see Materials and Methods).
Species are ordered such that in the upper part of the table fluidity differences are positive, e.g.,
B. anthracis (BA) has the lowest fluidity. The comparisons for which the null hypothesis that
the fluidity difference is not significant can be rejected with a p-value of 0.05 are noted with a ?,
whereas comparisons for which the null hypothesis cannot be rejected are noted with a ◦.
Ec Nm Sag Spy Spn Sau Ba
Ec × 5.70 10−1 7.87 10−1 2.16 10−2 8.57 10−8 8.93 10−20 5.42 10−27
Nm × 9.53 10−1 1.03 10−1 3.11 10−3 1.14 10−7 1.81 10−12
Sag × 4.49 10−1 3.35 10−1 8.03 10−2 1.22 10−2
Spy × 7.52 10−1 4.04 10−2 3.04 10−4
Spn × 9.53 10−6 2.44 10−12
Sau × 2.60 10−4
Ba ×
Table S3: p-values for fluidity differences for i = 0.5 and c = 0.5. Details of the significance test
are provided in the Materials and Methods.
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Nm Ec Sag Spy Spn Sau Ba
Nm × ◦ ◦ ◦ ? ? ?
Ec × ◦ ◦ ? ? ?
Sag × ◦ ◦ ◦ ?
Spy × ◦ ◦ ?
Spn × ? ?
Sau × ?
Ba ×
Table S4: Significant fluidity differences for i = 0.62 and c = 0.62. Species are ordered such that in
the upper part of the table fluidity differences are positive, e.g., B. anthracis (BA) has the lowest
fluidity. The comparisons for which the null hypothesis that the fluidity difference is not significant
can be rejected with a p-value of 0.05 are noted with a ?, whereas comparisons for which the null
hypothesis cannot be rejected are noted with a ◦.
Nm Ec Sag Spy Spn Sau Ba
Nm × 9.53 10−1 6.98 10−1 1.27 10−1 1.30 10−2 8.98 10−7 5.23 10−11
Ec × 7.00 10−1 8.33 10−2 7.71 10−5 5.66 10−16 1.13 10−22
Sag × 5.83 10−1 5.01 10−1 8.74 10−2 9.66 10−3
Spy × 9.22 10−1 5.58 10−2 7.41 10−4
Spn × 2.92 10−5 5.95 10−11
Sau × 1.58 10−3
Ba ×
Table S5: p-values for fluidity differences for i = 0.62 and c = 0.62. Details of the significance test
are provided in the Materials and Methods.
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Nm Ec Sag Spn Spy Sau Ba
Nm × ◦ ◦ ? ◦ ? ?
Ec × ◦ ? ◦ ? ?
Sag × ◦ ◦ ◦ ?
Spn × ◦ ? ?
Spy × ◦ ?
Sau × ?
Ba ×
Table S6: Significant fluidity differences for i = 0.74 and c = 0.74. Species are ordered such that in
the upper part of the table fluidity differences are positive, e.g., B. anthracis (BA) has the lowest
fluidity. The comparisons for which the null hypothesis that the fluidity difference is not significant
can be rejected with a p-value of 0.05 are noted with a ?, whereas comparisons for which the null
hypothesis cannot be rejected are noted with a ◦.
Nm Ec Sag Spn Spy Sau Ba
Nm × 4.68 10−1 3.28 10−1 2.30 10−2 1.10 10−1 5.34 10−6 6.37 10−10
Ec × 4.98 10−1 6.28 10−3 1.80 10−1 4.19 10−12 1.41 10−18
Sag × 8.37 10−1 8.24 10−1 1.47 10−1 1.13 10−2
Spn × 9.36 10−1 1.76 10−4 1.19 10−9
Spy × 9.21 10−2 1.54 10−3
Sau × 2.60 10−3
Ba ×
Table S7: p-values for fluidity differences for i = 0.74 and c = 0.74. Details of the significance test
are provided in the Materials and Methods.
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Rarest gene in 1/107 genomes
Rarest gene in 1/105 genomes











































Figure S1: The impact of gene rarity on pan genome size estimation. The left-hand panel shows
the gene frequency distribution of three genome models. The three models have the same common
genes (gene frequency larger than 10−2); they differ in the rare genes (the rare genes have frequency
10−7 in the blue model, 10−5 in the green model, and 10−3 in the red model). The number of rare
genes is chosen such that each genome consists of 2000 genes (on average). The right-hand panel
shows pan genome rarefaction data for different genome models. The genome models are listed
on the X-axis. The colored dashed lines indicate the position of the three genome models of the
left-hand panel. The full black line is the number of genes observed in a sample of 1 genome, 10
genomes and 100 genomes. The dashed black line is the true pan genome size of the genome model.
Note that with increasing rarity, there is little to no difference in observed genes (flat black lines)






























Figure S2: Schematic of Eq. (1) for calculating genomic fluidity based on tabulating the ratio of









Figure S3: Convergence of mean fluidity and its variance with increases in the number of sampled
genomes. Fluidity was calculated as described in the text given alignment parameters i = 0.50 and
c = 0.50. The variance of fluidity is estimated as a total variance, containing both the variance









Figure S4: Convergence of mean fluidity and its variance with increases in the number of sampled
genomes. Fluidity was calculated as described in the text given alignment parameters i = 0.62 and
c = 0.62. The variance of fluidity is estimated as a total variance, containing both the variance


























































































































































































































Figure S5: Estimates of fluidity depend on gene alignment parameters that determine the grouping
of genes into gene families. We calculated fluidity for each of the 7 species examined in the main
text with varying alignment parameter levels of identity (i) and coverage (c). We chose levels
such that 0.5 ≤ i ≤ 0.96 and 0.5 ≤ c ≤ 0.96. Computations of ϕ are based on estimating the
fraction of unique genes between any two random genomes. Unsurprisingly, fluidity increases with
increases in either i or c. This increase arises because greater stringency of alignment causes the
bioinformatics pipeline algorithm to infer that there are more unique genes. For each of the 7 species
examined, genomic fluidity is more sensitive to changes in identity than to changes in coverage. This
result suggests the importance of considering the robustness of results derived from bioinformatics
pipelines to changes in parameters. Despite the change in fluidity values, the actual value of fluidity
is relatively insensitive to changes in alignment parameters so long as neither parameter is greater
than approximately 0.8. Hence, in the main text we restrict sensitivity analyses to 0.5 ≤ i < 0.8
and 0.5 ≤ c < 0.8.
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